U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Best Practices for Communication Between IND Sponsors and FDA During Drug Development
  1. Search for FDA Guidance Documents

GOOD REVIEW PRACTICES

Best Practices for Communication Between IND Sponsors and FDA During Drug Development December 2017

Final
Docket Number:
FDA-2017-D-6564
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

1


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2017-D-6564.